136 related articles for article (PubMed ID: 10477451)
21. Defective apoptosis due to Bcl-2 overexpression may explain why B-CLL cells accumulate in G0.
Gottardi D; Alfarano A; De Leo AM; Stacchini A; Bergui L; Caligaris-Cappio F
Curr Top Microbiol Immunol; 1995; 194():307-12. PubMed ID: 7895503
[No Abstract] [Full Text] [Related]
22. Adaphostin-induced apoptosis in CLL B cells is associated with induction of oxidative stress and exhibits synergy with fludarabine.
Shanafelt TD; Lee YK; Bone ND; Strege AK; Narayanan VL; Sausville EA; Geyer SM; Kaufmann SH; Kay NE
Blood; 2005 Mar; 105(5):2099-106. PubMed ID: 15388586
[TBL] [Abstract][Full Text] [Related]
23. Induction of apoptosis using 2',2' difluorodeoxycytidine (gemcitabine) in combination with antimetabolites or anthracyclines on malignant lymphatic and myeloid cells. Antagonism or synergism depends on incubation schedule and origin of neoplastic cells.
Chow KU; Ries J; Weidmann E; Pourebrahim F; Napieralski S; Stieler M; Boehrer S; Rummel MJ; Stein J; Hoelzer D; Mitrou PS
Ann Hematol; 2000 Sep; 79(9):485-92. PubMed ID: 11043419
[TBL] [Abstract][Full Text] [Related]
24. CD40 triggering enhances fludarabine-induced apoptosis of chronic lymphocytic leukemia B-cells through autocrine release of tumor necrosis factor-alpha and interferon-gama and tumor necrosis factor receptor-I-II upregulation.
de Totero D; Tazzari PL; Capaia M; Montera MP; Clavio M; Balleari E; Foa R; Gobbi M
Haematologica; 2003 Feb; 88(2):148-58. PubMed ID: 12604404
[TBL] [Abstract][Full Text] [Related]
25. Synergistic Activity of Deguelin and Fludarabine in Cells from Chronic Lymphocytic Leukemia Patients and in the New Zealand Black Murine Model.
Rebolleda N; Losada-Fernandez I; Perez-Chacon G; Castejon R; Rosado S; Morado M; Vallejo-Cremades MT; Martinez A; Vargas-Nuñez JA; Perez-Aciego P
PLoS One; 2016; 11(4):e0154159. PubMed ID: 27101369
[TBL] [Abstract][Full Text] [Related]
26. Fludarabine induces apoptosis in chronic lymphocytic leukemia--the role of P53, Bcl-2, Bax, Mcl-1, and Bag-1 proteins.
Faria JR; Yamamoto M; Faria RM; Kerbauy J; Oliveira JS
Braz J Med Biol Res; 2006 Mar; 39(3):327-33. PubMed ID: 16501812
[TBL] [Abstract][Full Text] [Related]
27. Cytotoxic combination of loxoribine with fludarabine and mafosfamide on freshly isolated B-chronic lymphocytic leukemia cells.
Pellacani A; Tosi P; Zinzani PL; Ottaviani E; Albertini P; Magagnoli M; Tura S
Leuk Lymphoma; 1999 Mar; 33(1-2):147-53. PubMed ID: 10194132
[TBL] [Abstract][Full Text] [Related]
28. Killing of chronic lymphocytic leukemia by the combination of fludarabine and oxaliplatin is dependent on the activity of XPF endonuclease.
Zecevic A; Sampath D; Ewald B; Chen R; Wierda W; Plunkett W
Clin Cancer Res; 2011 Jul; 17(14):4731-41. PubMed ID: 21632856
[TBL] [Abstract][Full Text] [Related]
29. Chlorambucil synergizes with purine analogs in inducing in vitro cytotoxicity in B-cell chronic lymphocytic leukemia.
Callea I; Console G; Sculli G; Filangeri M; Messina G; Morabito F
Haematologica; 1998 Aug; 83(8):756-7. PubMed ID: 9793266
[TBL] [Abstract][Full Text] [Related]
30. Differential induction of apoptosis by fludarabine monophosphate in leukemic B and normal T cells in chronic lymphocytic leukemia.
Consoli U; El-Tounsi I; Sandoval A; Snell V; Kleine HD; Brown W; Robinson JR; DiRaimondo F; Plunkett W; Andreeff M
Blood; 1998 Mar; 91(5):1742-8. PubMed ID: 9473241
[TBL] [Abstract][Full Text] [Related]
31. The Hsp90 inhibitor NVP-AUY922-AG inhibits NF-κB signaling, overcomes microenvironmental cytoprotection and is highly synergistic with fludarabine in primary CLL cells.
Walsby E; Pearce L; Burnett AK; Fegan C; Pepper C
Oncotarget; 2012 May; 3(5):525-34. PubMed ID: 22619113
[TBL] [Abstract][Full Text] [Related]
32. Preclinical evaluation of gemcitabine combination regimens for application in acute myeloid leukemia.
Shanks RH; Rizzieri DA; Flowers JL; Colvin OM; Adams DJ
Clin Cancer Res; 2005 Jun; 11(11):4225-33. PubMed ID: 15930361
[TBL] [Abstract][Full Text] [Related]
33. ZGDHu-1 and fludarabine have a synergistic effect on apoptosis of chronic lymphocytic leukemia cells.
Qiu L; Liu J; Wang Z; Hu W; Huang Q; Zhou Y
Oncol Rep; 2015 Sep; 34(3):1239-48. PubMed ID: 26165829
[TBL] [Abstract][Full Text] [Related]
34. Engagement of alpha4beta1 integrin by fibronectin induces in vitro resistance of B chronic lymphocytic leukemia cells to fludarabine.
de la Fuente MT; Casanova B; Moyano JV; Garcia-Gila M; Sanz L; Garcia-Marco J; Silva A; Garcia-Pardo A
J Leukoc Biol; 2002 Mar; 71(3):495-502. PubMed ID: 11867687
[TBL] [Abstract][Full Text] [Related]
35. Cytotoxic activity of gemcitabine and correlation with expression profile of drug-related genes in human lymphoid cells.
Giovannetti E; Mey V; Loni L; Nannizzi S; Barsanti G; Savarino G; Ricciardi S; Del Tacca M; Danesi R
Pharmacol Res; 2007 Apr; 55(4):343-9. PubMed ID: 17296311
[TBL] [Abstract][Full Text] [Related]
36. Vitro drug-induced apoptosis in freshly isolated leukemic cells: a flow cytometric analysis.
Stagno F; Impera S; Italia P; Corsaro F; Cacciola E; Guglielmo P
Boll Soc Ital Biol Sper; 1995; 71(3-4):99-104. PubMed ID: 7646876
[TBL] [Abstract][Full Text] [Related]
37. Targeting lipid metabolism by the lipoprotein lipase inhibitor orlistat results in apoptosis of B-cell chronic lymphocytic leukemia cells.
Pallasch CP; Schwamb J; Königs S; Schulz A; Debey S; Kofler D; Schultze JL; Hallek M; Ultsch A; Wendtner CM
Leukemia; 2008 Mar; 22(3):585-92. PubMed ID: 18079738
[TBL] [Abstract][Full Text] [Related]
38. Roscovitine triggers apoptosis in B-cell chronic lymphocytic leukemia cells with similar efficiency as combinations of conventional purine analogs with cyclophosphamide.
Zolnierczyk JD; Błoński JZ; Robak T; Kiliańska ZM; Wesierska-Gadek J
Ann N Y Acad Sci; 2009 Aug; 1171():124-31. PubMed ID: 19723046
[TBL] [Abstract][Full Text] [Related]
39. 17p Deletion is associated with resistance of B-cell chronic lymphocytic leukemia cells to in vitro fludarabine-induced apoptosis.
Turgut B; Vural O; Pala FS; Pamuk GE; Tabakcioğlu K; Demir M; Ongören S; Soysal T; Algüneş C
Leuk Lymphoma; 2007 Feb; 48(2):311-20. PubMed ID: 17325891
[TBL] [Abstract][Full Text] [Related]
40. High expression of bfl-1 contributes to the apoptosis resistant phenotype in B-cell chronic lymphocytic leukemia.
Morales AA; Olsson A; Celsing F; Osterborg A; Jondal M; Osorio LM
Int J Cancer; 2005 Feb; 113(5):730-7. PubMed ID: 15499630
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
